Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-26 @ 5:00 PM
Study NCT ID:
NCT04345367
Status:
COMPLETED
Last Update Posted:
2022-07-08
First Post:
2020-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-11
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-13
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-27
First Submit QC Date:
None
Study First Post Date:
2020-04-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-06-09
Results First Submit QC Date:
None
Results First Post Date:
2022-07-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-09
Last Update Post Date:
2022-07-08
Last Update Post Date Type:
ACTUAL